Literature DB >> 7460715

Effect of oral bethanechol on parameters of esophageal peristalsis.

T J Humphries, D O Castell.   

Abstract

It has been suggested that enhanced esophageal peristalsis may be an additional reason for the therapeutic effect of oral bethanechol (B) in reflux patients and for the improved acid clearing seen with B. This study was designed to determine the effect of oral B on various parameters of esophageal peristalsis. Healthy young adult males were studied with an intraesophageal transducer assembly. Amplitude, dp/dt, and velocity profiles for the smooth muscle portion of the esophagus were produced. Oral B, 25 mg, produced a significant increase (P less than 0.05) in amplitude in the distal esophagus from 15 to 45 min after drug administration. The effect on dp/dt was similar but not as marked. Oral bethanechol produced decreases in velocity at all points, reaching significance (P less than 0.05) at the most distal measuring site, 30 and 45 min after injection. Oral B produces a stronger but slower, perhaps more efficient, progression of the peristaltic wave in normal humans. Our findings may explain improved acid clearance found with this agent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7460715     DOI: 10.1007/bf01312229

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  8 in total

1.  Esophageal motility.

Authors:  F J INGELFINGER
Journal:  Physiol Rev       Date:  1958-10       Impact factor: 37.312

2.  Effects of cholinergic stimulation on human esophageal peristalsis.

Authors:  J B Hollis; D O Castell
Journal:  J Appl Physiol       Date:  1976-01       Impact factor: 3.531

3.  Pressure profile of esophageal peristalsis in normal humans as measured by direct intraesophageal transducers.

Authors:  T J Humphries; D O Castell
Journal:  Am J Dig Dis       Date:  1977-07

4.  Serum gastrin concentrations following oral bethanechol with and without a meal.

Authors:  T J Humphries; R H Higgs; D O Castell; J E Mcguigan
Journal:  Am J Dig Dis       Date:  1978-03

5.  Cholinergic therapy of chronic heartburn. A controlled trial.

Authors:  R L Farrell; G T Roling; D O Castell
Journal:  Ann Intern Med       Date:  1974-05       Impact factor: 25.391

6.  Stimulation of the incompetent lower esophageal sphincter. A possible advance in therapy of heartburn.

Authors:  R L Farrell; G T Roling; D O Castell
Journal:  Am J Dig Dis       Date:  1973-08

7.  Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients.

Authors:  R W McCallum; M M Kline; N Curry; R A Sturdevant
Journal:  Gastroenterology       Date:  1975-05       Impact factor: 22.682

8.  Effect of bethanechol on gastroesophageal reflux.

Authors:  W N Miller; K P Ganeshappa; W J Dodds; W J Hogan; R F Barreras; R C Arndorfer
Journal:  Am J Dig Dis       Date:  1977-03
  8 in total
  4 in total

1.  Role of saliva in esophageal function and disease.

Authors:  J F Helm
Journal:  Dysphagia       Date:  1989       Impact factor: 3.438

2.  Oesophageal manometry: how well does it predict oesophageal function.

Authors:  C O Russell; G Whelan
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

3.  Relationship between swallow rate and salivary flow.

Authors:  Y V Kapila; W J Dodds; J F Helm; W J Hogan
Journal:  Dig Dis Sci       Date:  1984-06       Impact factor: 3.199

4.  Cisapride for gastro-oesophageal reflux and peptic oesophagitis.

Authors:  S Cucchiara; A Staiano; C Capozzi; C Di Lorenzo; A Boccieri; S Auricchio
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.